Labcode 13- HIV neutralization Protocol Pseudovirus in U87.CD4.CCR5 cells
- Quentin Sattentau
DOI Publisher
Harvard DataverseAbstract
This document contains a protocol for HIV neutralization utilizing Pseudovirus in U87.CD4.CCR5 cell
This document contains a protocol for HIV neutralization utilizing Pseudovirus in U87.CD4.CCR5 cell
HIV neutralization Protocol utilizing Chronically infected PM1 HIV-1/Hela Fusion Assa
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
<p>A panel of tier 1 and tier 2 HIV-1 pseudoviruses were tested against mAbs CH07, CH08, 17b, and 41...
This protocol includes a detailed protocol of HIV neutralizaion assay based on pseudovirus produced ...
This protocol describes the preparation and titration of pseudovirus (PV) and the detection of neutr...
This document contained a protocol on HIV neutralization utilizing recombinant viruses in HEK-293T c...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol describes a HIV neutralisation assay based on single cycle virus infectivity assay in ...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol describes a HIV neutralisation assay based on reduction in virus infectivity following...
This document contains a detailed protocol of a recombinant virus assay, developed to measure virus-...
This document contains a detailed protocol of the plaque reduction assays using human cell lines eng...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol describes a HIV neutralisation assay in the microtiter plate format, that measures red...
HIV neutralization Protocol utilizing Chronically infected PM1 HIV-1/Hela Fusion Assa
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
<p>A panel of tier 1 and tier 2 HIV-1 pseudoviruses were tested against mAbs CH07, CH08, 17b, and 41...
This protocol includes a detailed protocol of HIV neutralizaion assay based on pseudovirus produced ...
This protocol describes the preparation and titration of pseudovirus (PV) and the detection of neutr...
This document contained a protocol on HIV neutralization utilizing recombinant viruses in HEK-293T c...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol describes a HIV neutralisation assay based on single cycle virus infectivity assay in ...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol describes a HIV neutralisation assay based on reduction in virus infectivity following...
This document contains a detailed protocol of a recombinant virus assay, developed to measure virus-...
This document contains a detailed protocol of the plaque reduction assays using human cell lines eng...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol describes a HIV neutralisation assay in the microtiter plate format, that measures red...
HIV neutralization Protocol utilizing Chronically infected PM1 HIV-1/Hela Fusion Assa
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
<p>A panel of tier 1 and tier 2 HIV-1 pseudoviruses were tested against mAbs CH07, CH08, 17b, and 41...
Add to ORKG